Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of PharmacoGenomics for Reducing Adverse Drug Effects

NCT02081872 is registered in ClinicalTrials.gov with Companion Dx Reference Lab, LLC as lead sponsor.

NCT NCT02081872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02081872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Lead sponsor
Companion Dx Reference Lab, LLC
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2014
Completion date
July 31, 2017
Enrollment
279,000 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

genetics of drug metabolism